Skip to main content

Tetragon Partners GP Ltd

13F filer · CIK 0001515070
Reported Aug 13, 2026
Net buyer this quarter
13F portfolio value$635MU.S. long equity reported on 13F
Positions325 new · 7 closed
Net flow last quarter+$78.4MBuys minus sells
Top 10 positions weight74.0%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 13, 202632 positions
PATHUiPath, Inc.$336M52.98%Not reported+22.8%Q1 2022
KGEIKolibri Global Energy Inc.$33.8M5.33%19.27%Not reportedQ4 2023
AUTLAutolus Therapeutics plc$15.2M2.39%3.57%Not reportedQ2 2018
LYFTLyft, Inc.$14.6M2.30%0.26%Not reportedQ3 2019
DFTXDefinium Therapeutics, Inc.$13.5M2.13%0.21%+43.5%Q1 2026
WKWorkiva Inc$12.1M1.91%Not reportedNot reportedQ2 2025
CXMSprinklr, Inc.$11.4M1.79%2.30%Not reportedQ1 2022
MBXMBX Biosciences, Inc.$11.2M1.77%0.42%+39.9%Q3 2025
ALKTAlkami Technology, Inc.$10.9M1.71%0.56%NewQ2 2026
CLDXCelldex Therapeutics, Inc.$10.8M1.70%0.37%-7.0%Q4 2024
RLAYRelay Therapeutics, Inc.$10.7M1.68%0.26%+214.2%Q1 2025
ARWRArrowhead Pharmaceuticals, Inc.$10.6M1.67%0.09%+2.6%Q3 2025
PHVSPharvaris N.V.$10.2M1.61%0.45%+33.4%Q1 2025
ALKSAlkermes plc.$9.95M1.57%0.11%+18.9%Q2 2025
IMVTImmunovant, Inc.$9.86M1.55%0.12%+17.1%Q1 2025
SLNSilence Therapeutics plc$8.39M1.32%0.54%+21.3%Q4 2025
DYNDyne Therapeutics, Inc.$7.92M1.25%0.22%+38.2%Q2 2025
IONSIonis Pharmaceuticals Inc$7.7M1.21%0.06%+132.7%Q1 2026
AGIOAgios Pharmaceuticals, Inc.$7.63M1.20%0.34%+24.7%Q4 2025
HRMYHarmony Biosciences Holdings, Inc.$7.32M1.15%0.35%+68.5%Q4 2025
KRYSKrystal Biotech, Inc.$7.31M1.15%0.07%Not reportedQ3 2025
ANNXAnnexon, Inc.$7.09M1.12%0.83%-3.9%Q2 2024
CELCCelcuity Inc.$6.71M1.06%0.13%NewQ2 2026
WBDWarner Bros. Discovery, Inc.$6.67M1.05%0.01%-72.9%Q1 2026
NKTRNektar Therapeutics$6.07M0.96%0.43%-15.6%Q4 2025
AMLXAmylyx Pharmaceuticals, Inc.$5.35M0.84%0.27%-6.3%Q2 2025
ACADAcadia Pharmaceuticals Inc$4.25M0.67%0.10%+16.1%Q1 2025
CUECue Biopharma, Inc.$2.96M0.47%1.79%NewQ2 2026
SNOWSnowflake Inc.$2.55M0.40%0.00%Not reportedQ3 2020
ACRSAclaris Therapeutics, Inc.$2.12M0.33%0.29%NewQ2 2026
TECXTectonic Therapeutic, Inc.$1.6M0.25%0.24%+23.8%Q1 2025
GLUEMonte Rosa Therapeutics, Inc.$1.36M0.21%0.07%NewQ2 2026
Q1 2026Reported May 15, 202634 positions
PATHUiPath, Inc.$280M54.32%Not reported+44.5%Q1 2022
KGEIKolibri Global Energy Inc.$37.5M7.28%19.27%-1.4%Q4 2023
WBDWarner Bros. Discovery, Inc.$25.4M4.92%0.04%NewQ1 2026
WKWorkiva Inc$14.9M2.89%Not reported+66.7%Q2 2025
LYFTLyft, Inc.$13.3M2.58%0.25%Not reportedQ3 2019
CXMSprinklr, Inc.$13.2M2.56%2.30%Not reportedQ1 2022
AUTLAutolus Therapeutics plc$13.1M2.55%3.57%Not reportedQ2 2018
CLDXCelldex Therapeutics, Inc.$9.91M1.92%0.47%+28.1%Q4 2024
ARWRArrowhead Pharmaceuticals, Inc.$7.98M1.55%0.09%+31.2%Q3 2025
NKTRNektar Therapeutics$7.41M1.44%0.51%+48.7%Q4 2025
ANNXAnnexon, Inc.$7.16M1.39%0.87%-36.4%Q2 2024
PHVSPharvaris N.V.$6.26M1.22%0.34%+13.9%Q1 2025
ALKSAlkermes plc.$5.65M1.10%0.10%+13.2%Q2 2025
AGIOAgios Pharmaceuticals, Inc.$5.58M1.08%0.28%+1.7%Q4 2025
IMVTImmunovant, Inc.$5.43M1.05%0.11%+31.5%Q1 2025
PRAXPraxis Precision Medicines, Inc.$5.14M1.00%0.06%-30.5%Q4 2025
KRYSKrystal Biotech, Inc.$5.08M0.99%0.07%+66.5%Q3 2025
DYNDyne Therapeutics, Inc.$4.68M0.91%0.16%+4.1%Q2 2025
AMLXAmylyx Pharmaceuticals, Inc.$4.42M0.86%0.29%+16.5%Q2 2025
MBXMBX Biosciences, Inc.$4.34M0.84%0.31%+1.5%Q3 2025
DFTXDefinium Therapeutics, Inc.$3.78M0.73%0.19%NewQ1 2026
SLNOSoleno Therapeutics Inc$3.42M0.66%0.20%NewQ1 2026
AXSMAxsome Therapeutics, Inc.$3.39M0.66%0.04%-25.5%Q4 2024
HRMYHarmony Biosciences Holdings, Inc.$3.34M0.65%0.21%+44.1%Q4 2025
SLNSilence Therapeutics plc$3.32M0.64%0.44%+72.5%Q4 2025
ACADAcadia Pharmaceuticals Inc$3.22M0.62%0.08%Not reportedQ1 2025
IONSIonis Pharmaceuticals Inc$3.14M0.61%0.03%NewQ1 2026
MPLTMapLight Therapeutics, Inc.$2.28M0.44%0.25%-31.9%Q4 2025
RLAYRelay Therapeutics, Inc.$1.81M0.35%0.10%Not reportedQ1 2025
SNOWSnowflake Inc.$1.51M0.29%0.00%Not reportedQ3 2020
AARDAardvark Therapeutics, Inc.$1.19M0.23%1.45%NewQ1 2026
TECXTectonic Therapeutic, Inc.$1.16M0.23%0.20%Not reportedQ1 2025
RAREUltragenyx Pharmaceutical Inc.$827K0.16%0.04%Not reportedQ3 2025
KPTIKaryopharm Therapeutics Inc.$295K0.06%0.24%NewQ1 2026
Q4 2025Reported Feb 17, 202628 positions
PATHUiPath, Inc.$286M60.30%Not reported+3.0%Q1 2022
KGEIKolibri Global Energy Inc.$27.3M5.75%19.55%-1.9%Q4 2023
LYFTLyft, Inc.$19.4M4.08%0.25%Not reportedQ3 2019
AUTLAutolus Therapeutics plc$18.9M3.99%3.57%Not reportedQ2 2018
CXMSprinklr, Inc.$17.1M3.61%2.30%Not reportedQ1 2022
WKWorkiva Inc$12.9M2.73%Not reportedNot reportedQ2 2025
ANNXAnnexon, Inc.$10.2M2.15%1.36%-3.8%Q2 2024
PRAXPraxis Precision Medicines, Inc.$6.76M1.43%0.09%NewQ4 2025
CLDXCelldex Therapeutics, Inc.$6.62M1.40%0.37%-19.7%Q4 2024
ARWRArrowhead Pharmaceuticals, Inc.$6.44M1.36%0.07%+18.4%Q3 2025
PHVSPharvaris N.V.$5.4M1.14%0.30%Not reportedQ1 2025
AXSMAxsome Therapeutics, Inc.$4.92M1.04%0.05%-42.0%Q4 2024
DYNDyne Therapeutics, Inc.$4.85M1.02%0.15%+11.1%Q2 2025
MBXMBX Biosciences, Inc.$4.52M0.95%0.32%-19.4%Q3 2025
RAPTRAPT Therapeutics, Inc.$4.46M0.94%0.48%NewQ4 2025
AGIOAgios Pharmaceuticals, Inc.$4.41M0.93%0.28%NewQ4 2025
IMVTImmunovant, Inc.$4.22M0.89%0.08%-11.8%Q1 2025
ALKSAlkermes plc.$3.95M0.83%0.09%+57.5%Q2 2025
FOLDAmicus Therapeutics, Inc.$3.71M0.78%0.08%+115.1%Q3 2025
AMLXAmylyx Pharmaceuticals, Inc.$3.3M0.69%0.25%+5.7%Q2 2025
HRMYHarmony Biosciences Holdings, Inc.$3.1M0.65%0.14%NewQ4 2025
NKTRNektar Therapeutics$2.93M0.62%0.34%NewQ4 2025
KRYSKrystal Biotech, Inc.$2.91M0.61%0.04%+142.6%Q3 2025
MPLTMapLight Therapeutics, Inc.$2.89M0.61%0.37%NewQ4 2025
SLNSilence Therapeutics plc$2.22M0.47%0.26%NewQ4 2025
SNOWSnowflake Inc.$2.19M0.46%0.00%Not reportedQ3 2020
ZVRAZevra Therapeutics, Inc.$1.72M0.36%0.34%NewQ4 2025
AVDLAvadel Pharmaceuticals PLC$943K0.20%0.04%NewQ4 2025
Q3 2025Reported Nov 14, 202533 positions
PATHUiPath, Inc.$227M30.33%Not reported+23.5%Q1 2022
KGEIKolibri Global Energy Inc.$39.2M5.24%19.94%0.0%Q4 2023
LYFTLyft, Inc.$22M2.94%2.79%Not reportedQ3 2019
CXMSprinklr, Inc.$17M2.27%2.30%Not reportedQ1 2022
AUTLAutolus Therapeutics plc$15.5M2.07%3.57%Not reportedQ2 2018
WKWorkiva Inc$12.9M1.73%Not reportedNot reportedQ2 2025
CLDXCelldex Therapeutics, Inc.$7.85M1.05%0.46%-4.0%Q4 2024
TARSTarsus Pharmaceuticals, Inc.$7.43M0.99%0.29%-50.0%Q2 2023
ANNXAnnexon, Inc.$6.44M0.86%1.93%-24.8%Q2 2024
AXSMAxsome Therapeutics, Inc.$5.64M0.75%0.09%+11.9%Q4 2024
PHVSPharvaris N.V.$4.86M0.65%0.36%+3.5%Q1 2025
SRRKScholar Rock Holding Corp$4.39M0.59%0.12%+13.9%Q2 2025
TECXTectonic Therapeutic, Inc.$3.82M0.51%1.30%+6.5%Q1 2025
AMLXAmylyx Pharmaceuticals, Inc.$3.51M0.47%0.24%+18.1%Q2 2025
MBXMBX Biosciences, Inc.$3.11M0.42%0.40%NewQ3 2025
IMVTImmunovant, Inc.$3.04M0.41%0.11%+27.4%Q1 2025
DYNDyne Therapeutics, Inc.$2.82M0.38%0.16%+61.3%Q2 2025
ARWRArrowhead Pharmaceuticals, Inc.$2.82M0.38%0.06%NewQ3 2025
ALKSAlkermes plc.$2.69M0.36%0.05%+473.3%Q2 2025
ABVXAbivax S.A.$2.55M0.34%0.05%NewQ3 2025
SNOWSnowflake Inc.$2.26M0.30%0.00%Not reportedQ3 2020
ACADAcadia Pharmaceuticals Inc$1.84M0.25%0.05%-46.7%Q1 2025
HBMHudbay Minerals Inc.$1.78M0.24%0.03%+9.8%Q2 2015
CCJCameco Corp$1.34M0.18%0.00%-16.9%Q1 2025
RLAYRelay Therapeutics, Inc.$1.16M0.16%0.13%-68.1%Q1 2025
FOLDAmicus Therapeutics, Inc.$955K0.13%0.04%NewQ3 2025
KRYSKrystal Biotech, Inc.$860K0.11%0.02%NewQ3 2025
TECKTeck Resources Ltd$793K0.11%Not reported+183.7%Q1 2022
KROSKeros Therapeutics, Inc.$680K0.09%0.11%-66.4%Q4 2024
LARLithium Argentina AG$668K0.09%0.12%NewQ3 2025
RAREUltragenyx Pharmaceutical Inc.$533K0.07%0.02%NewQ3 2025
WBIWaterBridge Infrastructure LLC$504K0.07%Not reportedNewQ3 2025
NXENexGen Energy Ltd.$376K0.05%0.01%NewQ3 2025
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.